Belgian biopharma company UCB dedicated the site of its first U.S. manufacturing campus on Oct. 9. The planned biologics campus is in the Rowen innovation district in Gwinnett County, Georgia, and is part of a roughly $2 billion investment.
Georgia, Gwinnett County, and U.S. Commerce Department officials attended, along with Belgium’s consul general. UCB calls it one of the largest life sciences manufacturing investments in Georgia history.
The Dirt on the Deal
The campus will cover about 460,000 square feet on 79 acres. Per UCB, the investment is expected to:
Support more than 1,000 construction jobs
Create about 330 highly skilled permanent jobs
Generate about $5 billion in economic impact
That’s roughly three construction jobs for every permanent position.
Roundabout Reveal
A ribbon cutting marked the start of the project’s next phase of development. Guests also unveiled Emmanuel Janssen Circle, a commemorative stonework installation just completed in the roundabout at the entrance to the future campus.
It honors UCB’s founder and his family, who started the company nearly a century ago.
Smart Factory
UCB says the facility will use AI, automation, and advanced manufacturing technologies to make complex biologic medicines. It’s expected to support commercial production of recently approved and future biologics.
Peach State Pedigree
UCB established its U.S. headquarters in Atlanta in 1993 and employs more than 400 people in Georgia. It chose the state for its life sciences ecosystem, highly skilled workforce, robust infrastructure, and access to leading academic and research institutions.
The company is also seeking partnerships with local universities, schools, and workforce development organizations to develop Georgia’s next generation of biomanufacturing talent.
The stonework is done. Next up: about 460,000 square feet of campus.
🥾Want to advertise in TheJobWalk? Learn More🥾
